Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Alland

Showing results (21-30 of 153) with videos related to

Pageof 16
Sort By:
Plos One|December 25, 2013
Optimal triage test characteristics to improve the cost-effectiveness of the Xpert MTB/RIF assay for TB diagnosis: a decision analysisAnna H van't Hoog, Frank Cobelens, Anna Vassall, et al.
Medrxiv : the Preprint Server for Health Sciences|August 26, 2020
Use, reuse or discard: quantitatively defined variance in N95 respirator integrity following vaporized hydrogen peroxide decontamination during the COVID-19 pandemicCarly Levine, Courtney Grady, Thomas Block, et al.
Nature Communications|December 14, 2025
Divergent transcriptional regulation of redox-homeostasis and permeability modulate rifampicin tolerance and sensitivity in Mycobacterium tuberculosisJees Sebastian, Shuyi Ma, Tige Rustad, et al.
Antimicrobial Agents and Chemotherapy|May 4, 2016
High Systemic Exposure of Pyrazinoic Acid Has Limited Antituberculosis Activity in Murine and Rabbit Models of TuberculosisJean-Philippe Lanoix, Rokeya Tasneen, Paul O'Brien, et al.
Mbio|November 8, 2022
Origin and Dynamics of Mycobacterium tuberculosis Subpopulations That Predictably Generate Drug Tolerance and ResistanceJees Sebastian, Anooja Thomas, Carly Levine, et al.
Journal of Clinical Microbiology|November 3, 2006
Role of large sequence polymorphisms (LSPs) in generating genomic diversity among clinical isolates of Mycobacterium tuberculosis and the utility of LSPs in phylogenetic analysisDavid Alland, David W Lacher, Manzour Hernando Hazbón, et al.
Journal of Clinical Microbiology|May 28, 2010
Evaluation of the analytical performance of the Xpert MTB/RIF assayRobert Blakemore, Elizabeth Story, Danica Helb, et al.
Antimicrobial Agents and Chemotherapy|June 24, 2020
Rapidly Correcting Frameshift Mutations in the Mycobacterium tuberculosis <i>orn</i> Gene Produce Reversible Ethambutol Resistance and Small-Colony-Variant MorphologyHassan Safi, Subramanya Lingaraju, Shuyi Ma, et al.
Plos One|May 5, 2015
Comparative Evaluation of Sloppy Molecular Beacon and Dual-Labeled Probe Melting Temperature Assays to Identify Mutations in Mycobacterium tuberculosis Resulting in Rifampin, Fluoroquinolone and Aminoglycoside ResistanceSandy S Roh, Laura E Smith, Jong Seok Lee, et al.
Plos One|June 22, 2012
The structure of the oligomerization domain of Lsr2 from Mycobacterium tuberculosis reveals a mechanism for chromosome organization and protectionEmma L Summers, Kathrin Meindl, Isabel Usón, et al.
Pageof 16

Showing results (21-30 of 153) with videos related to

Sort By:
Pageof 16
Plos One|December 25, 2013
Optimal triage test characteristics to improve the cost-effectiveness of the Xpert MTB/RIF assay for TB diagnosis: a decision analysisAnna H van't Hoog, Frank Cobelens, Anna Vassall, et al.
Medrxiv : the Preprint Server for Health Sciences|August 26, 2020
Use, reuse or discard: quantitatively defined variance in N95 respirator integrity following vaporized hydrogen peroxide decontamination during the COVID-19 pandemicCarly Levine, Courtney Grady, Thomas Block, et al.
Nature Communications|December 14, 2025
Divergent transcriptional regulation of redox-homeostasis and permeability modulate rifampicin tolerance and sensitivity in Mycobacterium tuberculosisJees Sebastian, Shuyi Ma, Tige Rustad, et al.
Antimicrobial Agents and Chemotherapy|May 4, 2016
High Systemic Exposure of Pyrazinoic Acid Has Limited Antituberculosis Activity in Murine and Rabbit Models of TuberculosisJean-Philippe Lanoix, Rokeya Tasneen, Paul O'Brien, et al.
Mbio|November 8, 2022
Origin and Dynamics of Mycobacterium tuberculosis Subpopulations That Predictably Generate Drug Tolerance and ResistanceJees Sebastian, Anooja Thomas, Carly Levine, et al.
Journal of Clinical Microbiology|November 3, 2006
Role of large sequence polymorphisms (LSPs) in generating genomic diversity among clinical isolates of Mycobacterium tuberculosis and the utility of LSPs in phylogenetic analysisDavid Alland, David W Lacher, Manzour Hernando Hazbón, et al.
Journal of Clinical Microbiology|May 28, 2010
Evaluation of the analytical performance of the Xpert MTB/RIF assayRobert Blakemore, Elizabeth Story, Danica Helb, et al.
Antimicrobial Agents and Chemotherapy|June 24, 2020
Rapidly Correcting Frameshift Mutations in the Mycobacterium tuberculosis <i>orn</i> Gene Produce Reversible Ethambutol Resistance and Small-Colony-Variant MorphologyHassan Safi, Subramanya Lingaraju, Shuyi Ma, et al.
Plos One|May 5, 2015
Comparative Evaluation of Sloppy Molecular Beacon and Dual-Labeled Probe Melting Temperature Assays to Identify Mutations in Mycobacterium tuberculosis Resulting in Rifampin, Fluoroquinolone and Aminoglycoside ResistanceSandy S Roh, Laura E Smith, Jong Seok Lee, et al.
Plos One|June 22, 2012
The structure of the oligomerization domain of Lsr2 from Mycobacterium tuberculosis reveals a mechanism for chromosome organization and protectionEmma L Summers, Kathrin Meindl, Isabel Usón, et al.
Pageof 16